29
Active Trials
18
Phase 1
6
Phase 2
9
Phase 3
3
Therapeutic Areas
Portfolio Concentration: 117% of active trials in Oncology
Oncology
34 active / 34 total
Solid Tumor (Advanced)
12 active
12 total since 2015
CLL
8 active
6 Ph3
8 total since 2015
Non-Hodgkin Lymphoma
6 active
4 Ph3
6 total since 2015
Gastric Cancer
2 active
1 Ph3
2 total since 2015
Breast Cancer
2 active
2 total since 2015
Multiple Myeloma
1 active
1 total since 2015
Hepatocellular Carcinoma
1 active
1 total since 2015
NSCLC
1 active
1 total since 2015
HER2- Breast Cancer
1 active
1 total since 2015
Immunology
4 active / 4 total
Cardiovascular
2 active / 2 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)